JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (2): 56-58.doi: 10.6040/j.issn.1673-3770.0.2016.042

Previous Articles     Next Articles

Expression and clinical significance of serum HMGB1 in sinusitis patients.

ZHOU Xiaoyan1,4, LIN Peng2, SUN Shiming3, ZHANG Yana2, LI Xiaojie1, SHI Yukai   

  1. 1. The First Center Clinical College of Tianjin Medical University, Tianjin 300192, China;2. Tianjin First Center Hospital, Tianjin 300192, China;3. Tianjin Medical University General Hospital, Tianjin 300052, China;4. Tianjin Dongli Chinese Medical Hospital, Tianjin 300300, China
  • Received:2016-01-28 Online:2016-04-16 Published:2016-04-16

PDF (PC)

884

Abstract: Objective To investigate the expression and clinical significance of serum high mobility group box-1 protein(HMGB1)in chronic sinusitis patients. Methods A total of 32 sinusitis patients were enrolled in this study, of which 24 were type Ⅰ sinusitis, 8 were type Ⅱ sinusitis or type Ⅲ sinusitis. Meanwhile 8 healthy volunteers confirmed without infectious diseases or neoclassic diseases served as the control group. Enzyme-linked immunosorbent assays(ELISA)was applied to test cases’ serum HMGB1 level. Results (1)Sinusitis patients had higher level of serum HMGB1 than the control(P<0.05).(2)There was no significant difference of serum HMGB1 between type Ⅰ sinusitis patients and type Ⅱ and type Ⅲ sinusitis patients. Conclusion Chronic sinusitis patients have higher level of serum HMGB1 than normal people. Serum HMGB1 may serve as serum detection index for sinusitis patients. In addition, it provides the theoretic foundation for therapeutic target of sinusitis.

Key words: Enzyme-linked immunosorbent assays, High mobility group box protein, Sinusitis

CLC Number: 

  • R765.2
[1] Lotse M T, Traeey K J. High mobility group box 1 protein(HMGBl): nuclear weapon in the immune arsenal[J]. Nat Rev Immun, 2005, 5(4):331-334.
[2] Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice[J]. Science, 1999, 285(5425):248-251.
[3] 中华耳鼻咽喉科杂志编辑委员会,中华医学会耳鼻喉科分会.慢性鼻窦炎鼻息肉临床分型分期及内窥镜鼻窦手术疗效评定标准(1997,海口)[J].中华耳鼻咽喉科杂志,1998,33(3):6-6.
[4] Muller S, Scafidi P, Degryse B, et al. The double life of HMGBIchromatin protein:architectural factor and extracelhlar signal[J]. EMBO, 2001, 20(16):4337-4340.
[5] 姚咏明,刘辉.对高迁移率族蛋白Bl作用的新认识[J].中国危重病急救医学,2005,17(7):385-386.
[6] 杨超,吴传新,孙航孙,等.丙酮酸乙酯抑制脓毒症时HMGBl释放的分子机制[J].中山大学学报,2014,35(2):187-193.
[7] 王静,王炬,邓明明,等.乌司他丁对急性坏死性胰腺炎大鼠肝损伤中高迁移率族蛋白1表达的拮抗作用[J].中华消化杂志,2014,34(3):191-194.
[8] 刘婷,贺永文.原核构建高迁移率蛋白B1-A盒蛋白在小鼠急性肝功能衰竭中的保护作用及其机制[J].中华肝脏病杂志, 2010, 18(3):223-226. LIU Ting, HE Yongwen. Protective effect of recombinant HMGB1 A box protein in mouse with acute hepatic failure[J]. Chin J Hepatol, 2010, 18(3):223-226.
[1] FENG Sicong, YU Xiaolan, LOU Dan. Evaluation of the effect of Messerklinger middle turbinate plasty on chronic rhinosinusitis with nasal polyps based on the expression of Ki67 and GM-CSF in vesicular tissue [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 31-39.
[2] ZHAI Xuechun, BIAN Xin, CHEN Jingcai, DENG Jiayu, YE Zi, YANG Pingli. Characteristics and influencing factors of anxiety and depression in patients with chronic frontal sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 35-43.
[3] LI Yangsong, YUAN Fayang, YANG Yan, ZHANG Tian, YU Guodong. Bibliometric analysis of biologic agents for the treatment of chronic rhinosinusitis based on the Web of Science database [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 54-64.
[4] DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86.
[5] XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167.
[6] HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41.
[7] ZHANG Jiaqi, YUAN Ye, HONG Chen, GU Min, CHENG Lei, LU Meiping. Mendelian randomization study of gut microbiota, chronic sinusitis, and nasal polyps: Causal relationships and metabolite-mediated effects [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 49-60.
[8] ZHANG Guangling, CHEN Xingxue, WU Tianyi, SUN Zhanwei, WANG Weiwei, LI Shichao,WANG Guangke. The expression and function of Tespa1 in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 35-42.
[9] CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50.
[10] WANG Wenqing, ZHANG Dan, ZHU Mengdi, WANG Luyang, YANG Peipei, SUN Sisi, ZHANG Qiumin, ZHOU Hui. Changes of clinical and histopathological characteristics in recurrent chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 46-53.
[11] WANG Aowei, SHI Wenjie. Study on correlation between traditional Chinese medicine syndrome types and TFH cell related factors in CRSwNP [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 54-60.
[12] ZHANG Jie, NIMA Jizong, XU Xiaodong, ZHOU Jing, LIU Jianmin, LUO Yirui, DU Jintao, BA Luo. Effect of Crocin on Type 2 inflammation in eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 61-67.
[13] ZHANG Yunqiu, REN Xiumin, XU Ou, DONG Jinhui, WANG Jianxing. Research progress on omalizumab targeted therapy for chronic sinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 136-140.
[14] LI Ting, ZHAO Chong, WU Xian. The relationship between miR-34a expression in nasal mucosa tissue and postoperative recurrence in patients with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 20-25.
[15] CHEN Xingxue, ZHANG Guangling, WU Tianyi, WANG Weiwei, SUN Zhanwei, LI Shichao, WANG Guangke. Analysis of anti-IL-4Rα monoclonal antibody and endoscopic sinus surgery in the treatment of eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 43-54.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd